TD Cowen analyst Tim James says Cargojet’s (Cargojet Stock Quote, Chart, News, Analysts, Financials TSX:CJT) valuation does not reflect the company’s business resilience or potential earnings upside.
As reported by the Globe and Mail, James named Cargojet his “Canada Best Idea” and reiterated his “Buy” rating and $128.00 target. The average target is $121.85.
“We believe the drivers of past share price and valuation pressure are becoming less relevant and that the historically low valuation fails to reflect the business resiliency and earnings upside,” James said.
He said an eventual return to ACMI revenue growth, improved aircraft utilization and new ACMI and charter agreements could provide catalysts.
Last month Cargojet reported Q2 revenue of $275.8-million, up 15.8% year-over-year. Domestic network, ACMI and charter revenue rose 7.5% to $219.9-million, while fuel surcharge and other revenue increased 52.7% to $58.5-million.
Adjusted EBITDA was $87.3-million, up 8.9% from a year earlier, while free cash flow improved to $56.2-million from an outflow of $72.5-million.
Cargojet said its fuel pass-through mechanisms offset higher fuel costs in Q2, leaving no material impact on Adjusted EBITDA, though margins were compressed by about 260 basis points.
“Cargojet’s resilience and ability to adapt quickly to changing market and operational conditions continued to be key differentiators in the second quarter,” the company said in its MD&A.
The company said charter revenue rose $14.9-million, or 37.4%, as new charter opportunities replaced and exceeded revenue from transpacific flying in the prior year.
Cargojet also said free cash flow generation helped reduce its net debt-to-Adjusted EBITDA ratio to 2.6 times from 2.8 times, approaching its long-term target range of 1.5 times to 2.5 times.
James said those results support his view that the company’s fundamentals are improving as past pressures fade.
-30-
Roth Capital Partners analyst Boobalan Pachaiyappan says MediciNova (MediciNova Stock Quote, Chart, News, Analysts, Financials NASDAQ:MNOV) lead ALS drug could offer… [Read More]
Calian Group (Calian Group Stock Quote, Chart, News, Analysts, Financials TSX:CGY) has signed a strategic partnership with Ukrainian defence technology… [Read More]
Newhaven Asset Management CEO and portfolio manager Ryan Bushell says Telus (Telus Stock Quote, Chart, News, Analysts, Financials TSX:T) looks… [Read More]
TD Cowen analyst John Shao says longer-term demand visibility supports Celestica (Celestica Stock Quote, Chart, News, Analysts, Financials NYSE:CLS) as… [Read More]
Haywood Securities analyst Neal Gilmer says High Tide’s (High Tide Stock Quote, Chart, News, Analysts, Financials TSXV:HITI) record Q3 results… [Read More]
Haywood Securities analyst Gianluca Tucci says iFabric (iFabric Stock Quote, Chart, News, Analysts, Financials TSXV:IFA) has its strongest revenue pipeline… [Read More]